"Effects of agomelatine (25 to 50 mg/day) on sleep EEG parameters compared to escitalopram in patients with Major Depressive Disorder.
Phase of Trial: Phase II
Latest Information Update: 22 Dec 2017
At a glance
- Drugs Agomelatine; Serotonin uptake inhibitors
- Indications Major depressive disorder
- Focus Pharmacodynamics
- 16 Jul 2007 New trial record.